INS and type 1 diabetes mellitus: Although the preliminary sample size was limited by the availability of human donors, this pilot study provides valuable insights on the variation between human donors and sheds light on the challenges of developing synthetic peptides to improve the outcomes of islet transplant for the treatment of T1D that can face the high variability of insulin secretion patten among individuals.